Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 11, Pages 5767-5770
Publisher
American Society for Microbiology
Online
2013-08-27
DOI
10.1128/aac.01032-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recurrent Episodes of Candidemia Due to Candida glabrata with a Mutation in Hot Spot 1 of theFKS2Gene Developed after Prolonged Therapy with Caspofungin
- (2012) María Teresa Durán-Valle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden
- (2011) Marlene Axner-Elings et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media
- (2009) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of antifungal MICs for yeasts obtained using the EU-CAST method in a reference laboratory and the Etest in nine different hospital laboratories
- (2009) E. Dannaoui et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing
- (2008) M. Desnos-Ollivier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
- (2008) J.L. Rodriguez-Tudela et al. CLINICAL MICROBIOLOGY AND INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now